Latest Retinitis pigmentosa Stories

Retina Implant AG Principal Investigators Meet at ARVO 2013 Annual Meeting

2013-05-13 08:29:18

Top Retinal Surgeons Discuss Results and Learnings from Second Human Clinical Trial SEATTLE, May 13, 2013 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that the principal investigators met last week to discuss the results of the Company's second human clinical trial. Representatives from each clinical study site were in attendance, and the discussion was moderated by Professor...

Oxford BioMedica Announces Update from ARVO 2013

2013-05-09 04:21:22

OXFORD, England, May 9, 2013 /PRNewswire/ -- -- UshStat(R)video selected to showcase theme of "Life-changing Research" -- Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces an update from the 2013 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) held in Seattle, Washington (USA) on 5-9 May 2013. The ARVO annual meeting is the largest gathering of eye...

Blind Author, Determined to See Brighter Side of Life, Authors New Book

2013-04-13 23:03:04

Juanita McNeil releases inspirational guide to a pain-free life Richland, WA (PRWEB) April 13, 2013 From suffering abuse as a child to currently battling blindness, Juanita McNeil has overcome many challenges in her life. Though these hardships might keep many people down, they make McNeil strive to find the positives in life. At the age of 46, McNeil is currently attending school for her blindness caused by retinitis pigmentosa. Upon graduation from the Department for the Blind, she has...

Premier Biomedical, Inc. Announces Potential Therapy for Retinitis Pigmentosa

2013-02-21 08:31:32

ST. PETERSBURG, Fla., Feb. 21, 2013 /PRNewswire/ -- Premier Biomedical, Inc. (OTC-BB: BIEI) today announced that it has acquired exclusive rights to a provisional patent application against Retinitis Pigmentosa. This exclusive intellectual property right, a result of Premier's long-standing licensing agreements, proposes a novel method for treating the degenerative eye disease via the targeted removal of specified target antigens. This is the latest of many proposed applications of...

Retina Implant AG Announces the Publication of Study Results on its Alpha IMS Implant in Proceedings of the Royal Society B

2013-02-19 20:22:04

REUTLINGEN, Germany, Feb. 19, 2013 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced results from part of its multicentre study were published today in the peer-reviewed journal Proceedings of the Royal Society B. The research found that, during the course of a three to nine month observation period, functional vision was restored in the majority of nine German patients implanted with a...

New Artificial Retina Partially Restores Sight

High-Tech Artificial Retina Gets FDA Approval

2013-02-15 10:56:46

Jason Pierce, MSN, MBA, RN for redOrbit.com – Your Universe Online Today the US Food and Drug Administration (FDA) approved an artificial retina that is the first device of its kind to treat a form of progressive blindness that begins in young adulthood. The device will not completely restore vision, but it does allow the wearer to detect differences in light patterns and some shapes from their environment. The Argus II Retinal Prosthesis System, developed by Second Sight Medical...

Leading Researchers in Vision Impairment and Blindness to Present at EURETINA Winter Meeting

2013-02-01 08:25:55

ROME, Feb. 1, 2013 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), and Okuvision GmbH, an innovator in the field of transcorneal electrical stimulation (TES) therapy for early and intermediate stage RP patients, today announced that research on both companies' devices will be presented at the EURETINA Winter Meeting in Rome, Italy, February 1-3. Sister companies, Retina Implant and Okuvision have...

Foundation Fighting Blindness, Supermarket Industry Leaders and Parents of Visually Impaired Children Unite to Fight Blindness at “A Vision for the Future”

2013-01-16 23:03:36

Jan. 17 Event Will Honor Key Food Chief Executive; Special Guest Mrs. World Queens, NY (PRWEB) January 16, 2013 The Foundation Fighting Blindness, a national nonprofit that drives sight-saving research, will host its 2nd Annual ‘Una Visión Para El Futuro’ (A Vision for the Future) on Thursday, Jan. 17, at Terrace on the Park in Flushing Meadows Park. The event will honor the accomplishments and community involvement of Key Food Chief Executive Dean Janeway, as supermarket...

Herbal Remedy May Help Protect Against Macular Degeneration

Rosemary Compound Shown To Help Fight Macular Degeneration In Mouse Model

2012-11-28 09:03:33

April Flowers for redOrbit.com - Your Universe Online Herbal remedies have been used for thousands of years in Asia and early European cultures. In recent years, Western medicine has shown a renewed interest in herbs for their medicinal qualities, and scientists are now isolating the active compounds in many, documenting their antioxidant and anti-inflammatory activities. A new study led by the Sanford-Burnham Medical Research Institute (Sanford-Burnham) reports that carnosic acid,...

Okuvision GmbH Initiates Multi-Center, Post-Market Study

2012-11-08 08:35:59

REUTLINGEN, Germany, Nov. 8, 2012 /PRNewswire/ -- Okuvision GmbH, an innovator in the field of transcorneal electrical stimulation (TES) therapy for early and intermediate stage retinitis pigmentosa (RP) patients, today announced the start of a multi-center, post-market study for the company's CE marked OkuStim® treatment. OkuStim represents an advance in the treatment of RP, providing patients with a clinical option that has been shown to delay the progress of RP-related...